Content
American Cannabis MSO Portfolio Went UP 5% Last Week; Now +16% YTD
Article By:
Lorimer Wilson
Read
Wednesday, July 17, 2024 2:32 PM EDT
Despite the fact that all the constituents in the American Cannabis MSO Portfolio are faring poorly in 4 key financial metrics expressed as a % of net revenue the Portfolio was up 5.2% last week and is up 15.9% YTD and this article has the details.
Canadian Cannabis LP Portfolio Popped 11% Last Week; Now +18% YTD
Article By:
Lorimer Wilson
Read
Tuesday, July 16, 2024 3:30 PM EDT
The munKNEE Canadian Cannabis LP Portfolio is UP 17.5% YTD - and UP 10.7% last week - despite the fact that all its constituents are faring poorly in 4 key financial metrics expressed as a % of net revenue.
Clinical-Stage BioTech Drug Stocks Jumped 10% Last Week; UP 13% MTD
Article By:
Lorimer Wilson
Read
Sunday, July 14, 2024 11:17 AM EDT
The 10 clinical-stage AI-focused and psychedelic compound-based drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio are UP 12.8% MTD after having gone DOWN 13.2%, on average, in June and are now UP 13.8%, on average, YTD.
Canadian Cannabis LPs Doubled Performance Of American MSOs This Week
Article By:
Lorimer Wilson
Read
Sunday, July 14, 2024 5:46 AM EDT
The cannabis sector is extremely volatile with knee-jerk reactions in prices to any news so hopefully the information in this article will help our readers make informed decisions.
A Comparative Analysis Of The 12 Largest Cannabis Companies Puts Green Thumb #1
Article By:
Lorimer Wilson
Read
Wednesday, July 10, 2024 3:00 PM EDT
This article compares the Gross Profit margin; Selling General and Administration expenses; adjusted Earnings Before Interest, Taxes, Depreciation and Amortization and Net Profit Margin as a % of a Net Revenue of the 12 largest cannabis companies.
12 Largest Cannabis Stocks Declined +11%, On Average, In June
Article By:
Lorimer Wilson
Read
Monday, July 1, 2024 11:56 AM EDT
Last Friday the IRS made a statement that marijuana remained subject to the limitations of Internal Revenue Code Section 280E which prevents cannabis companies from claiming federal tax deductions until federal law changes.
Weekly Market Outlook – Technical Resistance Remains In The Way
Canada's 5 Largest Cannabis LPs Declined Another 6%, On Average, This Week
Article By:
Lorimer Wilson
Read
Sunday, June 23, 2024 1:17 AM EDT
None of the 5 constituents in the Canadian Cannabis LPs Portfolio advanced this week. They are now down 20%, on average, from where they were 8 weeks ago when the DEA announced it would be reclassifying cannabis to a less stringently regulated drug.
Largest Clinical-Stage Biotech Drug Stocks Declined 6%
Article By:
Lorimer Wilson
Read
Saturday, June 22, 2024 6:16 PM EDT
Of the 10 clinical-stage AI-focused and psychedelic compound-based small cap drug discovery companies in this portfolio, only 1 advanced this week. On average they were down 6% last week and -21.6% YTD.
Aurora Cannabis Q4 Financials Continue To Disappoint: Stock Declines
Article By:
Lorimer Wilson
Read
Friday, June 21, 2024 11:00 PM EDT
Despite the poor Q4 financial results the Company expects a Q1 2025 Net Revenue increase in the mid to high teens, an improvement in its operating cash flow and positive free cashflow by end of calendar year 2024.
In this article: ACB